Dapagliflozin*
-
API Product :
Dapagliflozin*
-
CEP :
-
-
WCC :
-
-
Therapeutic Use :
Drugs used in diabetes
-
Originator :
Bristol Myers Squibb
-
CAS No. :
4342-03-4
-
Trade Name. :
DTIC-DOME
-
Molecular Weight :
182.18 g/mol
-
Molecular Formula :
C6H10N6O
Application
Dapagliflozin is an oral diabetes medicine that helps controlblood sugar levels. Dapagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Dapagliflozin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus
General Description
Dapagliflozin (INN,[2] USAN,[3] trade name Farxiga far-SEE-g? in the U.S. and Forxiga in the EU and Russia) is a drug of the gliflozin class, used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca.